Subgroup one was enriched with tumour samples expressing high levels of IL‐11 (>75%, n = 16) whereas subgroup two was enriched in tumour samples with low levels of IL‐11 expression (<25%, n = 16). This evidence concerns the gene IL11 and neoplasm.